Crescent Pharma Limited is initiating a recall of a specific batch of Ramipril 2.5mg capsules due to a packaging error. This error may result in some cartons incorrectly containing blister strips of the higher dosage, Ramipril 10mg. The decision follows a report from a healthcare professional who found these discrepancies within a sealed carton.
Crescent Pharma’s Recall Details
The recall affects batch number GR155023. Both the Ramipril 2.5mg and Ramipril 10mg capsules were manufactured at the same facility, pointing to a mix-up during the packaging process.
About Ramipril
Ramipril is commonly prescribed for treating hypertension, kidney disease, and heart failure. It is crucial for consumers to verify the contents of their medication.
Instructions for Patients
- If you have Crescent Pharma’s Ramipril 2.5mg capsules, check the carton for batch number GR155023.
- Ensure that the medication strength on the carton matches the blister strips inside.
- If you find Ramipril 10mg blister strips, do not consume the medication.
- Contact your pharmacy immediately if errors are detected.
- If the blister strips are correctly labeled as Ramipril 2.5mg, continue your treatment as usual.
Potential Risks
Patients who may have consumed the incorrect dosage should be aware of potential side effects. Symptoms can include lightheadedness, fainting, fatigue, or altered kidney function. Vulnerable individuals may be at higher risk.
Next Steps for Affected Patients
If you suspect you have taken the incorrect dosage, seek medical advice promptly. Take the medication leaflet and any remaining tablets to your pharmacy or GP for further evaluation.
Action by Healthcare Professionals
The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed pharmacies and healthcare professionals to remove the impacted batch from distribution and return any remaining stock. This precaution is vital to ensure patient safety.
For further information, visit the MHRA’s official communications regarding this Class 2 recall. This agency plays a critical role in the regulation of medicines and medical devices, ensuring public health and safety.
